A study was conducted to evaluate the success and outcomes of electroanatomical-guided cardioneuroablation (EACNA) in treating patients with vagally induced atrioventricular blocks (VAVBs).
The results showed a high acute procedural success rate of 96.2%, but 14% of patients experienced recurrence of AVB or new syncopal episodes during a follow-up period of approximately 300 days.
The findings suggest that EACNA is a promising option for patients with VAVB, but further research is needed to explore its effects on daytime symptom burden.
* It focuses on the CNA-FWRD Registry, a multicenter prospective study that compares outcomes between patients receiving standard therapy and those undergoing cardioneuroablation over a follow-up period of three years.
* The findings aim to provide valuable data on long-term effects, recurrence of symptoms, and overall safety of cardioneuroablation, addressing a gap in existing research which is largely based on retrospective studies.